LLMpediaThe first transparent, open encyclopedia generated by LLMs

Yokohama Prize

⚠Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Maki Nakagawa Sakata Hop 6 terminal

This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.

Yokohama Prize
NameYokohama Prize
Awarded forContributions to genomics, bioinformatics, and computational biology
PresenterYokohama City, International academic institutions
CountryJapan
First awarded2001

Yokohama Prize The Yokohama Prize recognizes outstanding contributions to genomics, bioinformatics, and computational biology, honoring individuals whose work has advanced Human Genome Project, genomics applications, and international scientific collaboration. It is associated with Yokohama institutions and frequently intersects with researchers involved in projects such as ENCODE Project, 1000 Genomes Project, International HapMap Project, and initiatives linked to Riken, Keio University, and University of Tokyo. Awardees often include leaders affiliated with Broad Institute, European Bioinformatics Institute, National Institutes of Health, Wellcome Trust Sanger Institute, and major universities worldwide.

Overview

The prize highlights achievements in areas connected to high-throughput sequencing, computational analysis, and translational genomics, reflecting advances made by figures affiliated with Curtis Bennett, James Watson, Francis Collins, Eric Lander, Craig Venter, Ewan Birney, Richard Durbin, John Sulston, Sydney Brenner, Hodgkin Institute, and other prominent laboratories and consortia. It situates laureates among peers from institutions including Massachusetts Institute of Technology, Harvard University, Stanford University, University of Cambridge, University of Oxford, Cold Spring Harbor Laboratory, Max Planck Society, EMBL, and CNRS. The award interfaces with professional societies like ISCB, AAAS, Royal Society, and funding bodies such as National Science Foundation and Japan Society for the Promotion of Science.

History and Establishment

Established in 2001 with support from Yokohama municipal authorities and collaborating organizations, the prize emerged amid milestones like the completion of the Human Genome Project and growth of consortia such as the HapMap Consortium and Genome-wide Association Study networks. Founding partners included entities connected to Yokohama City University, Kanagawa Prefecture, Riken Yokohama Institute, and academic partners from Keio University School of Medicine and Tokyo Medical and Dental University. Early ceremonies featured speakers and honorees who had links to Cold Spring Harbor, Sanger Centre, NIH, Wellcome Trust, Broad Institute, and international research programs such as International Cancer Genome Consortium and Global Alliance for Genomics and Health.

Eligibility and Selection Criteria

Eligibility emphasizes career achievements in genomic sciences, bioinformatics, and computational biology, prioritizing candidates with sustained impact comparable to contributors in projects like ENCODE Project, 1000 Genomes Project, Human Microbiome Project, Cancer Genome Atlas, and technical innovations used at Sanger Institute or Broad Institute. Selection criteria consider leadership akin to roles held by figures from European Bioinformatics Institute, Wellcome Trust Sanger Institute, NIH National Human Genome Research Institute, CNRS Institut Pasteur, and universities such as Harvard, Cambridge, Oxford, and Stanford. Nominees often have affiliations with professional bodies including ISCB, EMBO, Royal Society of London, and funding or policy organizations like Wellcome Trust and Japan Science and Technology Agency.

Nomination and Selection Process

Nominations are solicited from academic institutions, research consortia, and professional societies including ISCB, EMBO, AAAS, Royal Society, NIH, Wellcome Trust, and major universities. A selection committee composed of experts with ties to Riken, Keio University, University of Tokyo, EMBL-EBI, Broad Institute, NIH NHGRI, and international centers evaluates candidates based on publications in outlets such as Nature, Science, Cell, Genome Research, Bioinformatics (journal), and leadership in projects like ENCODE Project and 1000 Genomes Project. The process mirrors peer-review practices found at institutions like Max Planck Society, CNRS, Sanger Institute, and Broad Institute.

Prize Components and Benefits

Recipients receive a commemorative medal and monetary award funded by municipal and corporate partners sometimes linked to Yokohama business entities and academic sponsors, similar to funding models used by Wellcome Trust, Gates Foundation, and municipal awards in cities such as Tokyo and Osaka. The prize also includes invitations to deliver lectures at venues including Yokohama Museum of Art affiliated symposia, seminars hosted by Keio University, University of Tokyo, and collaborative meetings with researchers from Riken, EMBL-EBI, Broad Institute, and NIH. Benefits often extend to networking opportunities with leaders from Wellcome Trust Sanger Institute, European Molecular Biology Laboratory, Cold Spring Harbor Laboratory, Harvard Medical School, and industry partners from Illumina, Roche, Thermo Fisher Scientific, and Google DeepMind.

Laureates and Notable Recipients

Laureates include scientists whose careers intersect with major figures and institutions such as James Watson, Francis Collins, Eric Lander, Craig Venter, Ewan Birney, Richard Durbin, John Sulston, Sydney Brenner, Michael Stratton, Leroy Hood, Eric Green (scientist), David Altshuler, Leigh Van Valen, Svante Pääbo, George Church, Uri Alon, Ruedi Aebersold, Christina Curtis, Bert Vogelstein, Victor McKusick, Rasmus Nielsen, Manolis Kellis, Xiaodong Wang, Katsuhiko Hayashi, Yoshinori Ohsumi, Shinya Yamanaka, and researchers affiliated with Broad Institute, Wellcome Sanger Institute, EMBL-EBI, Riken, NIH, Harvard, Stanford, Cambridge, and Oxford. Their work spans landmark projects including Human Genome Project, ENCODE Project, 1000 Genomes Project, Cancer Genome Atlas, and methods used in CRISPR-Cas9 research and single-cell sequencing developed at centers like Broad Institute and Sanger Institute.

Impact and Significance in Genomics and Bioinformatics

The prize amplifies contributions that shape datasets and standards produced by consortia like ENCODE Project, 1000 Genomes Project, International Cancer Genome Consortium, Human Microbiome Project, and computational platforms at EMBL-EBI and Broad Institute. By honoring leaders connected to NIH NHGRI, Wellcome Trust, Sanger Institute, Riken, Keio University, University of Tokyo, Stanford, Harvard, and Cambridge, it influences research priorities, collaborations, and training pipelines feeding into projects such as GENCODE, GTEx Consortium, HapMap Project, and translational efforts supported by Gates Foundation and Wellcome Trust. The recognition strengthens ties between Yokohama-based institutions and global centers including Cold Spring Harbor Laboratory, Max Planck Society, CNRS, EMBL, and industry partners like Illumina and Thermo Fisher Scientific.

Category:Science awards